Sanofi Takes Aim at Dengue Fever - Presented by: The Aol. On Network

It's the fastest-growing tropical disease, killing an estimated 20,000 people a year. Nearly half the world's population is at risk of contracting dengue fever. 100 million people each year are infected according to the World Health Organisation. France's Sanofi has been developing a dengue vaccine for the past 20 years. Now a large clinical study in five Asian countries showed the three-dose vaccine provides moderate protection against the disease.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 14.56 0.23 ▼ 1.56%
AKS $ 4.68 0.31 ▼ 6.21%
FCX $ 14 1.34 ▲ 10.58%
TVIX $ 3.83 0.21 ▲ 5.80%
F $ 13.56 0.53 ▼ 3.76%
AAPL $ 93.74 1.09 ▼ 1.15%
QQQ $ 105.72 0.56 ▼ 0.53%
VALE $ 5.67 0.05 ▲ 0.89%

As of 4/29/2016, 04:15 PM